The 12 closest competitors and alternatives to Enara Bio, Ltd. among biotech companies — ranked by similarity to what Enara Bio, Ltd. actually does, not by market-cap band.
Subscribe to see Enara Bio, Ltd.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Enara Bio, Ltd. is a UK biotechnology company that discovers cancer targets, including tumor-specific antigens, using immunopeptidomics and machine-learning technologies. It works with biopharmaceutical companies to support development of cancer vaccines and other targeted immunotherapies.
Enara Bio, Ltd. is a biotech company. Xcout tracks 15 named people at Enara Bio, Ltd., including Kevin Pojasek (President and CEO). Xcout recorded 2 job postings from Enara Bio, Ltd. in the last 90 days.
9 more named people on record for Enara Bio, Ltd., with roles, board committees and tenure — see the full roster →
Xcout recorded 2 job postings from Enara Bio, Ltd. in the last 90 days, from a hiring record Xcout has kept since September 2026.
The weekly hiring trend, the roles and locations behind it — see Enara Bio, Ltd.'s hiring signals →
Ranked by semantic similarity — how close each company is to Enara Bio, Ltd. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Noetik Inc. is an AI-native biotechnology company headquartered in South San Francisco, California, leveraging advanced machine learning methods for biological discovery.
Biotechnology
Sift Biosciences is a privately held biotechnology company founded in 2024 and headquartered in San Carlos, California. The company is focused on harnessing pre-existing hidden immunity.
Biotechnology
Lantern Pharma Inc. is a clinical-stage biotechnology firm dedicated to revolutionizing drug development through the strategic application of artificial intelligence, machine learning, and comprehensive genomic data analysis. Their primary drug candidate, LP-100, is currently undergoing Phase II clinical trials, targeting metastatic, castration-resistant prostate cancer. The company is also advancing LP-300 as a potential combination therapy for non-small cell lung cancer adenocarcinoma, specifically in individuals who are non-smokers or have never smoked. Furthermore, their preclinical pipeline includes LP-184, an alkylating agent engineered to inflict DNA damage upon cancer cells that either overexpress specific biomarkers or exhibit mutations within their DNA repair pathways. Beyond these, Lantern Pharma maintains an antibody-drug conjugate (ADC) program for diverse cancer treatments. Central to their operations is the RADR artificial intelligence platform, which synergizes molecular data through advanced big data analytics and machine learning capabilities. Established in 2013, the company operates from its headquarters in Dallas, Texas.
Healthcare
Gritstone bio, Inc. is a clinical-stage biotechnology company headquartered in Emeryville, California. The firm engages in developing next-generation cancer immunotherapies and vaccines to fight various forms of cancer and infectious diseases.
Healthtech
GATC Health Corp. is a biotechnology company that uses artificial intelligence, genomics, and toxicology data to discover and develop therapeutics and predict drug safety. Its work is aimed at pharmaceutical and biotechnology partners as well as patients needing treatments for serious diseases.
Biotechnology
Epitopea is a transatlantic cancer immunotherapeutics company operating from Montreal, Canada, and Cambridge, United Kingdom. Backed by life-science investors, the company develops novel therapeutics utilizing its proprietary CryptoMap platform.
Life Sciences
OncXerna Therapeutics is a clinical-stage precision-oncology biotechnology company that develops RNA-based biomarkers and targeted cancer therapies. Its work is intended to help identify cancer patients most likely to benefit from particular treatments and support oncologists and pharmaceutical partners in treatment selection.
Biotechnology
Impact Proteomics provides a proprietary antigen profiling and protein identification platform that analyzes patient samples to map disease-associated antigens without cloned intermediates. The company serves biotechnology and diagnostic partners by enabling target discovery, companion diagnostics development, and therapeutic selection for oncology and autoimmune diseases.
Similar biotech company
Elicera Therapeutics is a clinical-stage immuno-oncology company that develops genetically engineered cell and gene therapies, including CAR T-cell therapies and oncolytic viruses, to treat various types of cancer. The company utilizes its proprietary iTANK technology platform to enhance the immune system's ability to target and attack solid tumors.
Similar biotech company
PostEra Inc. is a U.S.-based biotechnology company that develops machine-learning and computational chemistry software for drug discovery and medicinal chemistry. Its platform helps pharmaceutical and biotechnology organizations design, prioritize, and manage experiments for small-molecule therapeutics.
Similar biotech company
Atavistik Bio is a U.S. biotechnology company developing small-molecule medicines by targeting allosteric sites and metabolite-regulated biology, using its chemoproteomics and drug-discovery platform. Its programs are aimed at treating cancer and other serious diseases.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Enara Bio, Ltd.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →